<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02278016</url>
  </required_header>
  <id_info>
    <org_study_id>xijing-120</org_study_id>
    <nct_id>NCT02278016</nct_id>
  </id_info>
  <brief_title>Biological Markers for the Diagnosis of Central Nervous System Infective Diseases</brief_title>
  <official_title>Diagnosis Value of Procalcitonin, Interleukin-6, AgiotensininⅡin the Cerebrospinal Fluid of Patients With Central Nervous System Infective Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bacterial meningitis is a potentially life-threatening disease that is associated with
      substantial neurological morbidity and mortality. Accurate diagnosis is essential to improve
      outcome and prevent antibiotic overuse. Here we try to explore new biological markers for the
      diagnosis of the central nervous system infection disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To investigate the diagnosis value of procalcitonin,interleukin-6, agiotensininⅡin the
      cerebrospinal fluid in the central nervous system infection disease.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Levels of procalcitonin, interleukin-6, agiotensininⅡ in the serum and cerebrospinal fluid</measure>
    <time_frame>36 months</time_frame>
    <description>meet the clinical diagnostic criteria for the central nervous system infection disease, the blood and cerebrospinal fluid samples after onset.</description>
  </primary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Infection</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      procalcitonin,interleukin-6,agiotensininⅡ
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        More than 12 years old; meet the clinical diagnostic criteria for the central nervous
        system infection disease
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Aged 13 years or older;

          2. At least two of the following clinical characteristics:headache, fever, neck
             stiffness, mental symptoms or consciousness impairment or seizures

          3. Patients' family signed informed consent.

        Exclusion Criteria:

          1. Contraindications to lumbar puncture

          2. Patients with active malignancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>jiang wen, MD</last_name>
    <role>Study Chair</role>
    <affiliation>The Department of Neurology , Xijing Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>jiang wen, MD</last_name>
    <phone>029-84771319</phone>
    <email>jiangwen@fmmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xijing Hospital</name>
      <address>
        <city>Xian</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jiang wen, MD</last_name>
      <phone>029-84771319</phone>
      <email>jiangwen@fmmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>jiang wen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2014</study_first_submitted>
  <study_first_submitted_qc>October 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 29, 2014</study_first_posted>
  <last_update_submitted>December 31, 2015</last_update_submitted>
  <last_update_submitted_qc>December 31, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>procalcitonin</keyword>
  <keyword>interleukin-6</keyword>
  <keyword>agiotensininⅡ</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcitonin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

